bluebird bio, Inc. vs 4D Molecular Therapeutics, Inc., risk disclosures compared

4topics both disclose

7only bluebird bio, Inc.

0only 4D Molecular Therapeutics, Inc.

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	bluebird bio, Inc.	4D Molecular Therapeutics, Inc.
Ransomware	18	3
Internal Control	6	6
Restatement	7	5
Third Party Risk Management	2	3

Only bluebird bio, Inc.

Topic	Filings
Audit Committee Oversight	2
Business Continuity	2
Consent Order	2
Data Breach	2
Material Weakness	2
Enforcement Action	1
Regulatory Investigation	1

Only 4D Molecular Therapeutics, Inc.

Nothing.

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

bluebird bio, Inc. · 4D Molecular Therapeutics, Inc. · All companies